The University Hospital Arnau de Vilanova is a public medical institution in Lleida, Catalonia, Spain, and the largest one in the surrounding area and province. It was opened in 1956.

During the past decade, Hospital Universitario Arnau de Vilanova, Servicio de Oncologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Arnau de Vilanova, Servicio de Oncologia" are "Ovarian Cancer" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Hospital Universitario Arnau de Vilanova, Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Arnau de Vilanova, Servicio de Oncologia" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abagovomab" (1 trials), "Gemcitabine (1000 mg/m2)" (1 trials), "Placebo" (1 trials) and "RP101" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Arnau de Vilanova, Servicio de Oncologia" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario Arnau de Vilanova, Servicio de Oncologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Universitario Arnau de Vilanova, Servicio de Oncologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Arnau de Vilanova, Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".